Massmutual Trust CO Fsb Seagen Inc. Transaction History

Massmutual Trust CO Fsb

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 03, 2023	BUY	$191.51 - $216.16 $4,596 - $5,187	24 Added 114.29%	45 $9,000
Q2 2023 Aug 01, 2023	BUY	$187.64 - $206.25 $750 - $825	4 Added 23.53%	21 $4,000
Q1 2023 Apr 11, 2023	BUY	$127.59 - $203.08 $1,275 - $2,030	10 Added 142.86%	17 $3,000
Q4 2022 Jan 06, 2023	SELL	$117.37 - $139.17 $352 - $417	-3 Reduced 30.0%	7 $1,000
Q3 2022 Oct 07, 2022	SELL	$135.27 - $180.11 $676 - $900	-5 Reduced 33.33%	10 $1,000

Q2 2022 Jul 07, 2022	BUY	$108.81 - $179.33 $1,632 - $2,689	15 New	15 $3,000
Q1 2022 Apr 08, 2022	SELL	$119.61 - $157.85 $956 - $1,262	-8 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$142.57 - $190.86 $855 - $1,145	-6 Reduced 42.86%	8 $1,000
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $1,891 - $2,255	14 New	14 $2,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

Stay updated on Massmutual Trust CO Fsb with notifications on news.